Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
Open Access
- 26 February 2013
- journal article
- research article
- Published by Hindawi Limited in ISRN Gastroenterology
- Vol. 2013, 1-5
Abstract
Objective. To explore fecal calprotectin levels in pediatric ulcerative colitis (UC) in relation with the validated clinical activity index PUCAI. Methods. This study included all 37 children (median age 14 years) with UC who had calprotectin measured (PhiCal ELISA Test) by the time of PUCAI assessment at the Children's Hospital of Helsinki in a total of 62 visits. Calprotectin values 1000 μg/g). The best cut-off value for calprotectin for predicting poor outcome was 800 μg/g (sensitivity 73%, specificity 72%; area under the ROC curve being 0.71 (95%CI 0.57–0.85)) and for the PUCAI best cut-off values >10 (sensitivity 62%, specificity 64%; area under the ROC curve 0.714 (95%CI 0.58–0.85)). Conclusion. The clinical relevance of somewhat elevated calprotectin during clinical remission in pediatric UC is not known and, until further evidence accumulates, does not indicate therapy escalation.Keywords
This publication has 24 references indexed in Scilit:
- Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric PatientsJournal of Pediatric Gastroenterology and Nutrition, 2012
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2011
- Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levelsWorld Journal of Gastroenterology, 2011
- Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring responseGut, 2010
- Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab studyAlimentary Pharmacology & Therapeutics, 2010
- Faecal calprotectin in children with clinically quiescent inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2010
- Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapyGut, 2007
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2006